Control Bionics Ltd.ASX: CBL

New US Insurance Code Approved

· Issued by Control Bionics Ltd.

Filed with ASX · · 4 pages · English

Summary by 6ix AI

Control Bionics Ltd. announced the approval of a new US Healthcare Common Procedure Coding System code for its NeuroNode device, which will allow for reimbursement in the US healthcare system. This approval is expected to significantly enhance the accessibility and insurance coverage of NeuroNode for users with impaired speech and motor function. Control Bionics anticipates that this development will create substantial opportunities for growth and expansion in the US market.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Control Bionics Ltd. on 6ix

Earlier from Control Bionics

Later from Control Bionics

All Control Bionics news releases